bmal1 silencing also caused a decreased rate of proliferation in the SW480 CRC cell line, an increase in glycolytic activity, and a modified response to the glucose transport inhibitor (VZB117) and OXA in SW480 and SW620 CRC cell lines [117]. The gene discussed is BMAL1; the disease is colorectal carcinoma.